Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Training Experience required

Oncology training commenced, ideally trial experience

General description of the institute

Sarah Cannon Research Institute is a dedicated Early Oncology Drug Development Unit ( at any one time ~ 40 open clinical trials) affiliated to 3 Tertiary Hospitals (Princess Grace, Harley Street Clinic and UCLH HCA/NHSVentures) where a broad spectrum of surgical, Haematology (Allo/Autograft) and Medical Oncology activities are performed. Dedicated Early Drug Development Unit, all tumour types covered.

Expertise

Early Drug Development, Genomics Review Board

Facilities

In and Outpatient facilities

Latest update: March 2021

host-institute-sarah-cannon-research-institute

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings